CXCL10 and vitiligo: Recently, a different study showed that serum CXCL10 levels were not just greater in vitiligo patients than in healthy controls but also associated with disease activity and reduced considerably following an effective therapeutic intervention, indicating it may be used as a biomarker to track the progression of the condition and the effectiveness of the therapeutic options [24].